-
2024 CACA Integrated Gastric Cancer Conference | Prof. Changqing Jing: Insights into Perioperative Immunotherapy for Gastric Cancer
The clinical use of immune checkpoint inhibitors (ICIs) offers a promising approach for locally advanced gastric and gastroesophageal junction (GEJ) cancers, potentially improving cure rates. Recent clinical trials have demonstrated that ICIs combined with chemotherapy, chemoradiotherapy, anti-HER2, or anti-VEGF agents exhibit synergistic and complementary effects. Compared to chemotherapy alone, these combinations show improved pathologic complete…
-
CCHIO 2024丨Dr. Lin Shen: Key Elements and Challenges in Precision Cancer Therapy
From November 14 to 17, 2024, the highly anticipated 2024 Chinese Congress on Holistic Integrative Oncology (CCHIO) was held in Xi’an. The event, hosted by the China Anti-Cancer Association and co-organized by the Shaanxi Anti-Cancer Association and the Institute for Development Strategy of Holistic Integrative Medicine , gathered leading experts in oncology.At the conference, Oncology…
-
2024 CACA Integrated Lung Cancer Conference | Dr. Gen Lin: Tackling Clinical Challenges, Breaking Through Evidence-Based to Precision Immunotherapy
The 2024 CACA Integrated Lung Cancer Conference, hosted by the Chinese Anti-Cancer Association and the Chinese Anti-Cancer Association’s Integrated Lung Cancer Committee (under preparation), was held in Zhuhai on October 25–26, 2024. With the theme “Uniting Efforts, Leading the Future,” the conference gathered leading domestic experts and scholars in the field of pulmonary tumors for…
-
2024 CACA Integrated Lung Cancer Conference | Dr. Weimin Li: Tailoring Strategies for Lung Nodule Risk Stratification to Empower Precision Lung Cancer
The 2024 CACA Integrated Lung Cancer Conference, hosted by the Chinese Anti-Cancer Association, was held in Zhuhai from October 25 to 26. Focusing on the theme “Gathering Strength, Leading the Future,” the conference brought together prominent experts in the field of lung cancer to discuss critical issues and advancements. Oncology frontier interviewed Dr. Weimin Li…
-
ASCO 2024 | Dr. Chang Liu: Dual Immunotherapy Offers New Options for PD-1 Resistant Gastric Cancer Patients
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting has successfully concluded, showcasing groundbreaking oncology research. Dr. Chang Liu from Professor Lin Shen’s team at Peking University Cancer Hospital presented their study on the efficacy and safety of CCR8 monoclonal antibody LM-108 combined with PD-1 antibody in gastric cancer patients. Professor Shen’s presentation at…
-
Dr. Ye Wei: Comprehensive Treatment and Guideline-Driven Care in Colorectal Cancer丨The CACA Guideline Journey Across China
Led by the Chinese Anti-Cancer Association (CACA), top oncology experts across various fields collaborated over a year to develop China’s first integrated oncology guideline, the CACA Integrated Cancer Diagnosis and Treatment Guideline, which was published in 2022. As part of a national educational tour on the guideline, Dr. Ye Wei from Huadong Hospital Affiliated to…
-
9th Academic Symposium of the CCIHPBA丨Dr. Tianqiang Song: Advancements in Perioperative Treatments for Liver Cancer and the Tianjin Experience
The 9th Academic Symposium of the Chinese Branch of the International Hepato-Pancreato-Biliary Association (IHPBA) was held in Wuhan from October 25-27, 2024, drawing renowned experts from over 20 countries, including the United States, Germany, France, Russia, and Australia. With more than 50 prominent international scholars, 21 academicians, and over 700 experts in liver, gallbladder, and…
-
Case Study丨Dr. Jia Shang: Diagnosis and Treatment of Invasive Fungal Infection in Severe Liver Disease Patients
Case Information The patient is a 61-year-old female who, five years ago, presented with “jaundice” at a local hospital, where she was diagnosed with cirrhosis. She subsequently came to our…
Connecting Medical Expertise through Media